{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Deerfield",
      "address_1": "One Takeda Parkway",
      "reason_for_recall": "Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.",
      "address_2": "Attn Supply Chain/Transportation",
      "product_quantity": "3,619 bottles",
      "code_info": "Lot # B21642; Exp. 03/17",
      "center_classification_date": "20150702",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Pharmaceuticals America, Inc., Deerfield, IL 60015, NDC 64764-890-99.",
      "report_date": "20150708",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Takeda Pharmaceuticals North America, Inc.",
      "recall_number": "D-1206-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "71516",
      "termination_date": "20180220",
      "more_code_info": "",
      "recall_initiation_date": "20150521",
      "postal_code": "60015",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}